Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 269 clinical trials
Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Ages 4 Weeks to <12 Years and <45 kg (MK-1439-066)

, who are treatment-naive (TN) or have been virologically suppressed (VS) on stable combination antiretroviral therapy (cART) for ≥3 months with no history of treatment failure. The first primary

hiv-1 rna measurement
immunodeficiency
lamivudine
tenofovir
HIV Vaccine
  • 0 views
  • 13 Apr, 2022
  • 13 locations
Prevention of HIV in "Île-de-France" (ANRS-PREVENIR)

; hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) vaccinations and post-exposure treatment of HIV infection as soon as possible after diagnosis using an antiretroviral combination

venereal disease
post-exposure prophylaxis
pre-exposure prophylaxis (prep)
antiretroviral agents
truvada
  • 5 views
  • 13 Jun, 2022
  • 2 locations
Community Based Interventions to Improve HIV Outcomes in Youth: a Cluster Randomised Trial in Zimbabwe (CHIEDZA)

A cluster randomised trial to determine the impact of an integrated community-based package of HIV services incorporating HIV testing, linkage to care and ongoing adherence support, combined with sexual and reproductive health (SRH) services and general health counselling for 16 to 24 year olds on population level HIV viral load …

hiv test
Accepts healthy volunteers
hiv viral load
HIV Vaccine
  • 18 views
  • 15 Feb, 2022
  • 3 locations
ADAPT for Adolescents Adolescents

Adolescents and young adults (AYA) with HIV face unique challenges to engagement in care and their ability to achieve optimal health outcomes. The investigators hypothesize that developmentally-tailored behavioral interventions will improve engagement in HIV care and viral suppression among AYA with HIV in Kenya. This two stage study will initially …

  • 0 views
  • 29 Jun, 2021
  • 1 location
TB Screening Improves Preventive Therapy Uptake (TB SCRIPT)

HIV-infected people have an increased risk of developing active tuberculosis (TB). To reduce the burden of TB among people living with HIV (PLHIV), the World Health Organization (WHO) recommends systematic TB screening followed by 1) confirmatory TB testing for all those who screen positive and 2) TB preventive therapy (TPT) …

tuberculosis
  • 0 views
  • 10 May, 2022
  • 1 location
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B (BEe-HIVe)

The purpose of this study is to evaluate response to and safety of the HBV vaccine HEPLISAV-B in two study populations living with HIV: prior HBV vaccine recipients who are deemed non-responders and individuals who are naïve to HBV vaccination.

vaccination
engerix-b
HIV Vaccine
  • 6 views
  • 13 Apr, 2022
  • 27 locations
Integration of Hypertension Management Into HIV Care in Nigeria

This study evaluates a tailored-practice facilitation (PF) strategy for integrating a task strengthening strategy for hypertension control (TASSH) for the care of patients living with HIV (PWH) within primary health centers (PHCs) in Lagos, Nigeria.

diabetes
stroke
hypertension
HIV Vaccine
  • 0 views
  • 26 Dec, 2021
  • 1 location
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2

The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to inform scale-up and sustainability of pediatric disclosure.

hiv diagnosis
HIV Vaccine
  • 0 views
  • 23 Sep, 2021
  • 1 location
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression (DATURA)

DATURA trial is a phase III, multicenter, two-arm, open-label, randomized superiority trial to compare the efficacy and the safety of an intensified tuberculosis (TB) regimen versus standard TB treatment in HIV-infected adults and adolescents hospitalized for TB with CD4 ≤ 100 cells/μL over 48 weeks: Intensified TB treatment regimen: increased …

  • 0 views
  • 11 May, 2022
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT) when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) as part of treatment for latent TB infection (LTBI) in HIV-1 and LTBI co-infected individuals.

hiv-1 rna measurement
hiv test
platelet count
body mass index
rifapentine
  • 20 views
  • 02 May, 2022
  • 10 locations